A startup’s psychedelic delivery tech is grabbing attention. Will pharma listen?

In the fast-developing market for pharma-grade psychedelic treatments, new niches have emerged. The impetus for biotech startup Psycheceutical, for example, wasn’t just about developing psychedelic therapies but leveraging a precision drug delivery tech.